Somehow I missed this in Sept. 2013.
It probably invalidates this trial; but I'm not paying to find out. Thats what your doctor is for.
The failed one here; no abstract.
The Lancet Neurology, Volume 12, Issue 11, Pages 1036 - 1037, November 2013
doi:10.1016/S1474-4422(13)70212-6Cite or Link Using DOI
Copyright © 2013 Elsevier Ltd All rights reserved.
Treatment
options for acute ischaemic stroke are slowly accruing and at present
include thrombolysis, aspirin, hemicraniectomy, and stroke-unit care.
However, two types of intervention have repeatedly not been shown to be
efficacious in trials: anticoagulation 1 and neuroprotection. 2 In
the past, neuroprotection referred to drugs that modulate
neurotransmission (eg, glutamate), but now the term is used by some
experts to include any type of intervention that preserves neuronal
structure and functio ...
To read this article in full you will need to login or make a payment
No comments:
Post a Comment